AMNEAL PHARMACEUTICALS, INC. Goodwill, Foreign Currency Translation Gain (Loss)
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$1.97 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-08-06
- AMNEAL PHARMACEUTICALS, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-06-30 was -$301.00K.
- AMNEAL PHARMACEUTICALS, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-03-31 was -$1.67M, a 2837.70% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-31 was -$475.00K.
- AMNEAL PHARMACEUTICALS, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-30 was -$1.46M.
- AMNEAL PHARMACEUTICALS, INC. goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$1.19M.
- AMNEAL PHARMACEUTICALS, INC. goodwill, foreign currency translation gain (loss) for fiscal 2023 was -$224.00K.
- AMNEAL PHARMACEUTICALS, INC. goodwill, foreign currency translation gain (loss) for fiscal 2022 was -$4.79M.
- AMNEAL PHARMACEUTICALS, INC. goodwill, foreign currency translation gain (loss) for fiscal 2021 was -$381.00K.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month as first filed | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$301.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.97M 10-Q · filed 2026-08-06 | -$2.45M derived: sum of 3 quarters · filed 2026-08-06 | -$3.91M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$1.67M 10-Q · filed 2026-05-07 | -$2.15M derived: sum of 2 quarters · filed 2026-08-06 | -$3.61M derived: sum of 3 quarters · filed 2026-08-06 | -$3.70M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | -$475.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-06 | -$1.94M derived: sum of 2 quarters · filed 2026-08-06 | -$2.03M derived: sum of 3 quarters · filed 2026-08-06 | -$1.97M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.55M derived: sum of 2 quarters · filed 2025-11-06 | -$1.49M 10-Q · filed 2025-11-06 | -$2.38M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2025-06-30 | -$91.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$30.00K 10-Q · filed 2025-08-07 | -$918.00K derived: sum of 3 quarters · filed 2026-02-27 | -$1.13M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2025-03-31 | $61.00K 10-Q · filed 2025-05-07 | -$827.00K derived: sum of 2 quarters · filed 2026-02-27 | -$1.04M derived: sum of 3 quarters · filed 2026-02-27 | -$1.05M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-12-31 | -$888.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$1.10M derived: sum of 2 quarters · filed 2026-02-27 | -$1.11M derived: sum of 3 quarters · filed 2026-02-27 | -$1.19M 10-K · filed 2026-02-27 | |
| 2024-09-30 | -$209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$225.00K derived: sum of 2 quarters · filed 2024-11-12 | -$305.00K 10-Q · filed 2024-11-12 | -$307.00K derived: sum of 4 quarters · filed 2025-02-28 | |
| 2024-06-30 | -$16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$96.00K 10-Q · filed 2024-08-09 | -$98.00K derived: sum of 3 quarters · filed 2025-02-28 | -$96.00K derived: sum of 4 quarters · filed 2025-02-28 | |
| 2024-03-31 | -$80.00K 10-Q · filed 2024-05-08 | -$82.00K derived: sum of 2 quarters · filed 2025-02-28 | -$80.00K derived: sum of 3 quarters · filed 2025-02-28 | -$607.00K derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | -$527.00K derived: sum of 3 quarters · filed 2025-02-28 | -$224.00K 10-K · filed 2025-02-28 | |
| 2023-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$525.00K derived: sum of 2 quarters · filed 2024-05-08 | -$222.00K 10-Q · filed 2023-11-09 | -$873.00K derived: sum of 4 quarters · filed 2024-05-08 | |
| 2023-06-30 | -$527.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08 | -$224.00K 10-Q · filed 2024-05-08 | $353.00K 10-Q · filed 2023-08-08 | -$875.00K derived: sum of 3 quarters · filed 2024-05-08 | -$2.35M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-03-31 | $303.00K 10-Q · filed 2023-05-09 | -$348.00K derived: sum of 2 quarters · filed 2024-03-14 | -$1.82M derived: sum of 3 quarters · filed 2024-03-14 | -$3.74M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-12-31 | -$651.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$2.12M derived: sum of 2 quarters · filed 2024-03-14 | -$4.04M derived: sum of 3 quarters · filed 2024-03-14 | -$4.79M 10-K · filed 2024-03-14 | |
| 2022-09-30 | -$1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$3.39M derived: sum of 2 quarters · filed 2022-11-07 | -$4.14M 10-Q · filed 2022-11-07 | -$4.28M derived: sum of 4 quarters · filed 2023-03-03 | |
| 2022-06-30 | -$1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$2.67M 10-Q · filed 2022-08-08 | -$2.81M derived: sum of 3 quarters · filed 2023-03-03 | -$2.80M derived: sum of 4 quarters · filed 2023-03-03 | |
| 2022-03-31 | -$752.00K 10-Q · filed 2022-05-06 | -$895.00K derived: sum of 2 quarters · filed 2023-03-03 | -$880.00K derived: sum of 3 quarters · filed 2023-03-03 | -$1.08M derived: sum of 4 quarters · filed 2023-03-03 | |
| 2021-12-31 | -$143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | -$128.00K derived: sum of 2 quarters · filed 2023-03-03 | -$325.00K derived: sum of 3 quarters · filed 2023-03-03 | -$381.00K 10-K · filed 2023-03-03 | |
| 2021-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$182.00K derived: sum of 2 quarters · filed 2021-11-08 | -$238.00K 10-Q · filed 2021-11-08 | -$114.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2021-06-30 | -$197.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$253.00K 10-Q · filed 2021-08-09 | -$129.00K derived: sum of 3 quarters · filed 2022-03-01 | $197.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2021-03-31 | -$56.00K 10-Q · filed 2021-05-07 | $68.00K derived: sum of 2 quarters · filed 2022-03-01 | $394.00K derived: sum of 3 quarters · filed 2022-03-01 | $301.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $450.00K derived: sum of 2 quarters · filed 2022-03-01 | $357.00K derived: sum of 3 quarters · filed 2022-03-01 | -$369.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $326.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $233.00K derived: sum of 2 quarters · filed 2020-11-06 | -$493.00K 10-Q · filed 2020-11-06 | -$660.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2020-06-30 | -$93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$819.00K 10-Q · filed 2020-08-06 | -$986.00K derived: sum of 3 quarters · filed 2021-03-01 | -$1.33M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2020-03-31 | -$726.00K 10-Q · filed 2020-05-11 | -$893.00K derived: sum of 2 quarters · filed 2021-03-01 | -$1.24M derived: sum of 3 quarters · filed 2021-03-01 | -$1.13M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-12-31 | -$167.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$513.00K derived: sum of 2 quarters · filed 2021-03-01 | -$403.00K derived: sum of 3 quarters · filed 2021-03-01 | -$292.00K 10-K · filed 2021-03-01 | |
| 2019-09-30 | -$346.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$236.00K derived: sum of 2 quarters · filed 2019-11-07 | -$125.00K 10-Q · filed 2019-11-07 | $402.00K derived: sum of 4 quarters · filed 2020-03-02 | |
| 2019-06-30 | $110.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $221.00K 10-Q · filed 2019-08-05 | $748.00K derived: sum of 3 quarters · filed 2020-03-02 | -$176.00K derived: sum of 4 quarters · filed 2020-03-02 | |
| 2019-03-31 | $111.00K 10-Q · filed 2019-05-09 | $638.00K derived: sum of 2 quarters · filed 2020-03-02 | -$286.00K derived: sum of 3 quarters · filed 2020-03-02 | ||
| 2018-12-31 | $527.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$397.00K derived: sum of 2 quarters · filed 2020-03-02 | -$1.71M 10-K · filed 2020-03-02 | ||
| 2018-09-30 | -$924.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$2.23M 10-Q · filed 2018-11-07 | |||
| 2018-06-30 | -$1.31M 10-Q · filed 2018-08-09 | ||||
| 2017-12-31 | $1.90M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |